AU2013285996B2 - A system and method for improved diffuse luminescent imaging or tomography in scattering media - Google Patents
A system and method for improved diffuse luminescent imaging or tomography in scattering media Download PDFInfo
- Publication number
- AU2013285996B2 AU2013285996B2 AU2013285996A AU2013285996A AU2013285996B2 AU 2013285996 B2 AU2013285996 B2 AU 2013285996B2 AU 2013285996 A AU2013285996 A AU 2013285996A AU 2013285996 A AU2013285996 A AU 2013285996A AU 2013285996 B2 AU2013285996 B2 AU 2013285996B2
- Authority
- AU
- Australia
- Prior art keywords
- excitation
- luminescence
- luminescent
- imaging
- light
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000003384 imaging method Methods 0.000 title claims abstract description 107
- 238000000034 method Methods 0.000 title claims abstract description 98
- 238000003325 tomography Methods 0.000 title claims abstract description 37
- 230000005284 excitation Effects 0.000 claims abstract description 299
- 239000003550 marker Substances 0.000 claims abstract description 95
- 238000004020 luminiscence type Methods 0.000 claims abstract description 93
- 238000001514 detection method Methods 0.000 claims abstract description 18
- 238000006862 quantum yield reaction Methods 0.000 claims description 58
- 230000008569 process Effects 0.000 claims description 24
- 239000000523 sample Substances 0.000 claims description 13
- 241001465754 Metazoa Species 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 238000002428 photodynamic therapy Methods 0.000 claims description 10
- 206010028980 Neoplasm Diseases 0.000 claims description 9
- 230000005281 excited state Effects 0.000 claims description 9
- 238000002595 magnetic resonance imaging Methods 0.000 claims description 9
- 238000001727 in vivo Methods 0.000 claims description 7
- 230000007704 transition Effects 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 6
- 238000004364 calculation method Methods 0.000 claims description 6
- 239000002872 contrast media Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000002596 diffuse optical imaging Methods 0.000 claims description 5
- 238000010869 super-resolution microscopy Methods 0.000 claims description 5
- 201000011510 cancer Diseases 0.000 claims description 4
- 238000000338 in vitro Methods 0.000 claims description 4
- 239000002086 nanomaterial Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- 238000004557 single molecule detection Methods 0.000 claims description 4
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 3
- 239000000090 biomarker Substances 0.000 claims description 3
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 claims description 3
- 150000002251 gadolinium compounds Chemical class 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 230000005298 paramagnetic effect Effects 0.000 claims description 3
- HQHVZNOWXQGXIX-UHFFFAOYSA-J sodium;yttrium(3+);tetrafluoride Chemical compound [F-].[F-].[F-].[F-].[Na+].[Y+3] HQHVZNOWXQGXIX-UHFFFAOYSA-J 0.000 claims description 2
- 230000003213 activating effect Effects 0.000 claims 1
- 239000011253 protective coating Substances 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 11
- 239000002105 nanoparticle Substances 0.000 description 38
- 230000001965 increasing effect Effects 0.000 description 30
- 238000013459 approach Methods 0.000 description 17
- 230000008901 benefit Effects 0.000 description 14
- 230000000694 effects Effects 0.000 description 14
- 238000000799 fluorescence microscopy Methods 0.000 description 11
- 230000001419 dependent effect Effects 0.000 description 10
- 238000001228 spectrum Methods 0.000 description 10
- 150000002500 ions Chemical class 0.000 description 9
- 230000009102 absorption Effects 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 238000005286 illumination Methods 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 238000000386 microscopy Methods 0.000 description 7
- 238000005424 photoluminescence Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000002708 enhancing effect Effects 0.000 description 5
- 239000002159 nanocrystal Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000009543 diffuse optical tomography Methods 0.000 description 4
- 238000000295 emission spectrum Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004088 simulation Methods 0.000 description 4
- KFKRXESVMDBTNQ-UHFFFAOYSA-N 3-[18-(2-carboxylatoethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-21,24-diium-2-yl]propanoate Chemical compound N1C2=C(C)C(C(C)O)=C1C=C(N1)C(C)=C(C(O)C)C1=CC(C(C)=C1CCC(O)=O)=NC1=CC(C(CCC(O)=O)=C1C)=NC1=C2 KFKRXESVMDBTNQ-UHFFFAOYSA-N 0.000 description 3
- VYXSBFYARXAAKO-WTKGSRSZSA-N chembl402140 Chemical compound Cl.C1=2C=C(C)C(NCC)=CC=2OC2=C\C(=N/CC)C(C)=CC2=C1C1=CC=CC=C1C(=O)OCC VYXSBFYARXAAKO-WTKGSRSZSA-N 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229940028435 intralipid Drugs 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 238000012634 optical imaging Methods 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002616 MRI contrast agent Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011258 core-shell material Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 150000004673 fluoride salts Chemical class 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003908 quality control method Methods 0.000 description 2
- -1 rare earth ions Chemical class 0.000 description 2
- 229910052761 rare earth metal Inorganic materials 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004154 testing of material Methods 0.000 description 2
- 208000007204 Brain death Diseases 0.000 description 1
- 229910052691 Erbium Inorganic materials 0.000 description 1
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 1
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000012632 fluorescent imaging Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000005090 green fluorescent protein Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229910052747 lanthanoid Inorganic materials 0.000 description 1
- 150000002602 lanthanoids Chemical class 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004001 molecular interaction Effects 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000009022 nonlinear effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003504 photosensitizing agent Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 229910003366 β-NaYF4 Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/47—Scattering, i.e. diffuse reflection
- G01N21/4795—Scattering, i.e. diffuse reflection spatially resolved investigating of object in scattering medium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0073—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by tomography, i.e. reconstruction of 3D images from 2D projections
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Radiology & Medical Imaging (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261666899P | 2012-07-01 | 2012-07-01 | |
| US61/666,899 | 2012-07-01 | ||
| US201361771131P | 2013-03-01 | 2013-03-01 | |
| US61/771,131 | 2013-03-01 | ||
| PCT/EP2013/063878 WO2014006012A1 (en) | 2012-07-01 | 2013-07-01 | A system and method for improved diffuse luminescent imaging or tomography in scattering media |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013285996A1 AU2013285996A1 (en) | 2015-02-05 |
| AU2013285996B2 true AU2013285996B2 (en) | 2017-01-19 |
Family
ID=48741153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013285996A Active AU2013285996B2 (en) | 2012-07-01 | 2013-07-01 | A system and method for improved diffuse luminescent imaging or tomography in scattering media |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10143380B2 (enExample) |
| EP (1) | EP2867653B1 (enExample) |
| JP (1) | JP6443934B2 (enExample) |
| KR (1) | KR102100614B1 (enExample) |
| CN (1) | CN104603600B (enExample) |
| AU (1) | AU2013285996B2 (enExample) |
| CA (1) | CA2879769C (enExample) |
| IL (1) | IL236424A0 (enExample) |
| WO (1) | WO2014006012A1 (enExample) |
| ZA (1) | ZA201409381B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112014010848B1 (pt) * | 2011-11-08 | 2022-12-27 | Koninklijke Philips N.V | Sistema e método para anotação interativa de uma imagem, estação de trabalho, aparelho gerador de imagens |
| US10387698B2 (en) * | 2015-02-19 | 2019-08-20 | South Dakota Board Of Regents | Reader apparatus for upconverting nanoparticle ink printed images |
| JP6966942B2 (ja) * | 2015-06-05 | 2021-11-17 | アップル インコーポレイテッドApple Inc. | 表示パネル用の発光制御装置及び方法 |
| KR101700287B1 (ko) * | 2015-06-17 | 2017-01-31 | 전호상 | 단층촬영에서의 양자검출효율 측정용 팬텀 및 이를 이용한 양자검출효율 측정방법 |
| US10603001B2 (en) | 2015-07-01 | 2020-03-31 | General Electric Company | Energy modulated luminescence tomography |
| US12019074B2 (en) | 2017-06-08 | 2024-06-25 | Lumito Ab | Method of analysing a sample for at least one analyte |
| KR102253350B1 (ko) * | 2017-12-20 | 2021-05-18 | 주식회사 고영테크놀러지 | 옵티컬 트래킹 시스템 및 옵티컬 트래킹 방법 |
| KR102166372B1 (ko) | 2017-12-20 | 2020-10-15 | 주식회사 고영테크놀러지 | 옵티컬 트래킹 시스템 및 옵티컬 트래킹 방법 |
| US11872068B2 (en) | 2018-11-05 | 2024-01-16 | Socpra Sciences Et Génie S.E.C. | Pulsed X-ray imaging |
| NL2022223B1 (en) * | 2018-12-17 | 2020-07-03 | Lumicks Tech B V | Microscopy method and system |
| JP7240995B2 (ja) * | 2019-09-17 | 2023-03-16 | 株式会社アドバンテスト | ファントムおよび蛍光検出装置 |
| CN114923884A (zh) * | 2022-04-06 | 2022-08-19 | 清华大学 | 测量上转换材料中镧系元素离子本征弛豫速率参数的方法 |
| CN116285575B (zh) * | 2023-03-15 | 2024-03-29 | 北京机电工程总体设计部 | 一种焰流烧蚀实验背温微区成像涂料、制备及使用方法 |
| EP4439133A1 (en) | 2023-03-27 | 2024-10-02 | Lumito AB | A microscope for upconverting nanoparticles |
| CN118349824B (zh) * | 2024-03-29 | 2024-12-24 | 昆明理工大学 | 一种星载全波形激光雷达回波的最优脉宽高斯分解方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001272343A (ja) * | 2000-03-23 | 2001-10-05 | Olympus Optical Co Ltd | 二重共鳴吸収顕微鏡 |
| CA2458802C (en) * | 2001-09-06 | 2016-06-07 | Genomic Profiling Systems, Inc. | Rapid and sensitive detection of molecules |
| CN102497803B (zh) * | 2009-05-05 | 2015-03-25 | 卢米托股份有限公司 | 用于散射介质中改进的扩散发光成像或者断层照相的系统、方法和发光标记物 |
-
2013
- 2013-07-01 CA CA2879769A patent/CA2879769C/en active Active
- 2013-07-01 EP EP13732953.8A patent/EP2867653B1/en active Active
- 2013-07-01 AU AU2013285996A patent/AU2013285996B2/en active Active
- 2013-07-01 KR KR1020157002498A patent/KR102100614B1/ko active Active
- 2013-07-01 WO PCT/EP2013/063878 patent/WO2014006012A1/en not_active Ceased
- 2013-07-01 CN CN201380035375.5A patent/CN104603600B/zh active Active
- 2013-07-01 US US14/412,198 patent/US10143380B2/en active Active
- 2013-07-01 JP JP2015519182A patent/JP6443934B2/ja active Active
-
2014
- 2014-12-19 ZA ZA2014/09381A patent/ZA201409381B/en unknown
- 2014-12-23 IL IL236424A patent/IL236424A0/en unknown
Non-Patent Citations (1)
| Title |
|---|
| GAINER C. F., et al., "Toward the Use of Two-Color Emission Control in Upconverting NaYF4:Er3+, Yb3+ Nanoparticles for Biomedical Imaging", Proceedings SPIE, Vol. 8231, February 2012, pages 1-8. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104603600A (zh) | 2015-05-06 |
| AU2013285996A1 (en) | 2015-02-05 |
| CA2879769A1 (en) | 2014-01-09 |
| WO2014006012A1 (en) | 2014-01-09 |
| JP6443934B2 (ja) | 2018-12-26 |
| US20150196201A1 (en) | 2015-07-16 |
| CN104603600B (zh) | 2017-09-01 |
| ZA201409381B (en) | 2017-08-30 |
| KR102100614B1 (ko) | 2020-04-14 |
| KR20150043299A (ko) | 2015-04-22 |
| JP2015525587A (ja) | 2015-09-07 |
| CA2879769C (en) | 2022-06-21 |
| US10143380B2 (en) | 2018-12-04 |
| EP2867653B1 (en) | 2020-09-16 |
| IL236424A0 (en) | 2015-02-26 |
| EP2867653A1 (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013285996B2 (en) | A system and method for improved diffuse luminescent imaging or tomography in scattering media | |
| CA2877437A1 (en) | Method and arrangement for the relative position detection of stations by means of radio location | |
| AU2010244431B2 (en) | A system, method, and luminescent marker for improved diffuse luminescent imaging or tomography in scattering media | |
| US5832931A (en) | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents | |
| CN105891170B (zh) | 活体动物双光子激发延时检测荧光成像分析方法及设备 | |
| JP2015525587A5 (enExample) | ||
| Meng et al. | Rare earth-doped nanocrystals for bioimaging in the near-infrared region | |
| Jung et al. | Quantum dot imaging in the second near-infrared optical window: studies on reflectance fluorescence imaging depths by effective fluence rate and multiple image acquisition | |
| Tan et al. | Rare earth-doped nanoparticles for advanced in vivo near infrared imaging | |
| WO2000071028A1 (en) | Improved methods and apparatus for multi-photon photo-activation and detection of molecular agents | |
| Trifanova et al. | Photoluminescent α-NaYbF4: Er0. 02Ce0. 02Zn0. 1 nanoparticles for bioimaging in visible and infrared ranges | |
| Svensson et al. | Upconverting luminescence imaging and tomography for biomedical applications | |
| HK1021127A (en) | Method for improved selectivity in photo-activation and detection of molecular diagnostic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |